Bone Mineral Density
Investigators examined the effect of consuming a Mediterranean-style diet for 1 year on inflammatory response and bone health in the elderly.
The risk for bone fractures was not increased in patients with type 2 diabetes using empagliflozin compared with placebo or glimepiride.
High levels of serotonin are predictive of an increased risk for hip fracture, nonvertebral osteoporotic fracture, and incident fractures in older men.
Romosozumab increased bone mineral density in postmenopausal women through increased bone formation and decreased bone resorption.
Men with accelerated bone loss have lower estimated bone strength, poorer trabecular microarchitecture, and thinner cortices compared with men without accelerated bone loss.
Investigators sought to determine whether both restrictive and purging types of anorexia nervosa effect bone metabolism.
Gastric bypass surgery can have damaging effects on bone mass as early as 6 months postoperatively.
Routine vitamin D and calcium supplementation in older adults is not supported for lowering the incidence of osteoporosis-related fractures.
Tocilizumab treatment for 2 years was shown to reduce levels of bone loss in patients with ACPA-positive RA.
Growth hormone therapy may reduce the risk for fracture in patients with osteoporosis.
The UK National Osteoporosis Guideline Group released updated guidelines for the prevention of fragility fracture in postmenopausal women and in men aged 50 years or older.
Total hip BMD was associated with heart failure risk in black and non-black men, with an interaction by race.
Researchers compared the efficacy of dual-energy x-ray absorptiometry with lateral x-ray in assessing vertebral fractures.
This week, a phase III trial for investigational drug voclosporin for lupus nephritis treatment was approved, prolonged insomnia may lead to less robust bone formation — causing osteoporosis and bone fractures — and researchers found that women who drink a moderate amount of alcohol daily have a reduced risk of developing systemic lupus erythmatosus.
Three-year fracture study examines the effects of osteoporosis drug denosumab on fractures, bone mineral density, and bone turnover markers in postmenopausal women with osteoporosis.
Prospective observational cohort study examines association between post-ICU administration of anti-fracture therapy or glucocorticoids and longitudinal changes in bone mineral density.
Testosterone treatments help improve volumetric bone mineral density and bone strength in elderly men with low testosterone.
The trabecular bone score may provides an acute, albeit indirect, measurement of bone quality in patients with type 2 diabetes.
Study examines the predictive value for vertebral fractures of bone mineral density and bone turnover markers after a 5-year drug holiday.
Long-term tenofovir treatment for hepatitis B infection is linked with abnormal phosphorus metabolism in a recent study.
Lorraine Fitzpatrick, MD, discusses updated results from the ACTIVE phase 3 clinical trial.
Higher Trabecular Bone Scores were found in postmenopausal women taking hormone replacement therapy compared with women who had never used hormone therapy.
DMARDs have been shown to be effective in halting progressive bone loss in rheumatoid arthritis.
Pediatric and adolescent patients who used stimulants to treat ADHD were found to have low bone density and bone mineral content.
Kenneth Saag, MD, president of the National Osteoporosis Foundation (NOF), co-chair of the National Bone Health Alliance, and Rheumatology Advisor advisory board member, reports on the recent changes that have led to the current state of osteoporosis treatment in the US.
Findings showing that sedentary time was not significantly linked to bone mineral density weaken the previous association between physical activity and bone mineral density.
The use of ARBs was associated with lower incidence of non-vertebral fractures than ACE inhibitors or CCBs.
Denosumab treatment led to significant increases in BMD at the lumbar spine and total hip at 12 months as compared to risedronate, both in patients receiving continuing glucocorticoid therapy and those just starting glucocorticoid therapy.
To better predict bone loss during the menopausal transition, researchers created the bone balance index using bone turnover markers to measure net bone formation.
Interval changes in bone mineral density (BMD) detected by dual-energy x-ray absorptiometry (DXA) are associated with fracture risk in women starting osteoporosis treatment
Rheumatology Advisor Articles
- 5-Step Guide to Activity Tracker Use for Patients With Rheumatic Diseases
- Gout Associated With Worse Outcomes in Obstructive Coronary Artery Disease
- Filgotinib Effective for Treatment of Active Psoriatic Arthritis
- Standard Set of Outcomes Developed for Value-Based Health Care in Inflammatory Arthritis
- Clinically Meaningful Improvement in Rheumatoid Arthritis Assessed With RAPID-3
- Circadian Rhythm in Rheumatoid Arthritis: Using Chronotherapy to Improve Outcomes
- Transcutaneous Electrical Nerve Stimulation Reduces Pain, Fatigue in Fibromyalgia
- Aspirin, Anticoagulants Similarly Prevent VTE After TKA
- Study: Cold Weather Joint Pain and Other Weather-Related Pain
- Increased Opioid Prescribing Linked to Chronic Usage in Patients With RA
- Treatment Retention Rates Lower in Patients Switching From Originator to Biosimilar Etanercept
- Climate Change Expected to Lead to Rise in Lyme Disease
- Red Cell Distribution Width Linked to Cardiovascular Disease Risk Factors in Spondyloarthritis
- Higher Biologic Drug Survival in JIA With Younger Age at Treatment Initiation
- Enough Is Enough? When Health Metrics Shift From Useful to Too Much